Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

by University of California, Los AngelesResearchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encep

Updated on: April 01,2024

Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

by University of California, Los AngelesResearchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encep

Updated on:April 01,2024

Nearly a third of Americans use gray market caregivers to aid the elderly and those with dementia

by RAND CorporationCredit: CC0 Public DomainNearly a third of Americans who arranged for paid care for an older person or someone with dementia employed workers who were not hired through a regul

Updated on: July 01,2024

Nearly a third of Americans use gray market caregivers to aid the elderly and those with dementia

by RAND CorporationCredit: CC0 Public DomainNearly a third of Americans who arranged for paid care for an older person or someone with dementia employed workers who were not hired through a regul

Updated on:July 01,2024

Nearly one-third of patients with TBI have marginal or inadequate health literacy

by Wolters Kluwer HealthCredit: Wikimedia CommonsLow health literacy is a problem for a substantial proportion of people with moderate to severe traumatic brain injury (TBI),according

Updated on: March 30,2024

Nearly one-third of patients with TBI have marginal or inadequate health literacy

by Wolters Kluwer HealthCredit: Wikimedia CommonsLow health literacy is a problem for a substantial proportion of people with moderate to severe traumatic brain injury (TBI),according

Updated on:March 30,2024

P-glycoprotein removes Alzheimer's-associated toxin from the brain

by Southern Methodist University(A) The first frame of SMU's simulation shows amyloid-β bound to the drug binding domains of P-gp. (B) The final frame of the same simulation shows P-gp pushin

Updated on: April 01,2024

P-glycoprotein removes Alzheimer's-associated toxin from the brain

by Southern Methodist University(A) The first frame of SMU's simulation shows amyloid-β bound to the drug binding domains of P-gp. (B) The final frame of the same simulation shows P-gp pushin

Updated on:April 01,2024

Five things to know when a loved one is diagnosed with Alzheimer's

by University of Southern CaliforniaCredit: AI-generated imageSeeing the personality and whole being erased in loved ones with Alzheimer's disease can be a heart-wrenching experience.Mental h

Updated on: May 20,2024

Five things to know when a loved one is diagnosed with Alzheimer's

by University of Southern CaliforniaCredit: AI-generated imageSeeing the personality and whole being erased in loved ones with Alzheimer's disease can be a heart-wrenching experience.Mental h

Updated on:May 20,2024

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th

Updated on: February 28,2024

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th

Updated on:February 28,2024

Research team develops social app to support Alzheimer's caregivers

by Indiana UniversityEvery day, more than 15 million unpaid caregivers provide care to people with Alzheimer's disease, with little outside support and often at the risk of their own health.N

Updated on: February 28,2024

Research team develops social app to support Alzheimer's caregivers

by Indiana UniversityEvery day, more than 15 million unpaid caregivers provide care to people with Alzheimer's disease, with little outside support and often at the risk of their own health.N

Updated on:February 28,2024

Study finds how Alzheimer's-associated protein tangles spread through the brain

by Massachusetts General HospitalDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Massachusetts General Hospital (MGH) investigators have discovered

Updated on: February 26,2024

Study finds how Alzheimer's-associated protein tangles spread through the brain

by Massachusetts General HospitalDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Massachusetts General Hospital (MGH) investigators have discovered

Updated on:February 26,2024

Alzheimer's disease may cause vicious circle between brain network and immune cell dysfunctions

by Sarah C.p. Williams,Gladstone InstitutesA new study by Gladstone scientists suggests that certain anti-epileptic or tau-reducing treatments could be promising for people in the early stages o

Updated on: April 10,2024

Alzheimer's disease may cause vicious circle between brain network and immune cell dysfunctions

by Sarah C.p. Williams,Gladstone InstitutesA new study by Gladstone scientists suggests that certain anti-epileptic or tau-reducing treatments could be promising for people in the early stages o

Updated on:April 10,2024

FAU site for first US clinical trial for Lewy Body dementia

by Florida Atlantic UniversityThe South Florida clinical trial is directed by one of the world's leading neuroscientists and an expert on LBD, James E. Galvin, M.D., M.P.H., a professor of cl

Updated on: February 28,2024

FAU site for first US clinical trial for Lewy Body dementia

by Florida Atlantic UniversityThe South Florida clinical trial is directed by one of the world's leading neuroscientists and an expert on LBD, James E. Galvin, M.D., M.P.H., a professor of cl

Updated on:February 28,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on: March 07,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on:March 07,2024

Rosacea linked to a slightly increased risk of dementia

by WileyA new study has uncovered an increased risk of dementia—in particular Alzheimer's disease—in patients with rosacea. Importantly, the risk was highest in older patients and in patients

Updated on: February 28,2024

Rosacea linked to a slightly increased risk of dementia

by WileyA new study has uncovered an increased risk of dementia—in particular Alzheimer's disease—in patients with rosacea. Importantly, the risk was highest in older patients and in patients

Updated on:February 28,2024